Approval · Notice of Compliance 3309 · 1997
SURVANTA: Notice of Compliance 3309
Issued December 3, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3309
- Date
- December 3, 1997
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing
- Therapeutic class
- Natural surfactant from bovine lung
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SURVANTA | 02016109 | Marketed |
Medicinal ingredients
- BERACTANT 25 MG per ML